Clinical Trials Directory

Trials / Unknown

UnknownNCT03786601

Postmenopausal Women With Vaginal Microbiota

High-risk HPV Infection and Vaginal Microbiota in Postmenopausal Women

Status
Unknown
Phase
Study type
Observational
Enrollment
1 (estimated)
Sponsor
Peking Union Medical College Hospital · Academic / Other
Sex
Female
Age
20 Years – 75 Years
Healthy volunteers

Summary

Since other genital infections enhance HIV susceptibility by inducing inflammation, the investigators study the relationship between the vaginal microbiota composition and the risk of HPV infection, cervical cytological abnormalities in postmenopausal women.

Detailed description

Persistent infection with oncogenic Human Papillomavirus (HPV) is necessary but not sufficient for the development of cervical cancer. Additional factors correlated with HPV persistence include immunodeficiency caused by HIV, smoking, use of oral contraceptives and, more recently reported, vaginal dysbiosis. In a state of dysbiosis, there is a marked reduction of Lactobacillus and a high diversity of bacteria, with increased abundance of anaerobic bacterial species. Owing to the decrease of estrogen level and cervical atrophy in postmenopausal women, cervical cytology is more prone to abnormal changes than in premenopausal women. Clinically, cervical lesions in elderly women are easily neglected. Therefore, cervical cancer in the elderly is usually found in advanced stage, with poor prognosis and more complications of treatment. Based on this, the investigators are going to analyze the changes of microbiota in women with high-risk HPV and the cervical lesions in menopausal women. And the investigators hope to figure out the difference and change in microbiota to realize the tanning of cervical lesions.

Conditions

Interventions

TypeNameDescription
OTHERObservationThe participants were assigned to different groups according to the results of HPV detection.

Timeline

Start date
2018-12-25
Primary completion
2019-12-01
Completion
2020-07-01
First posted
2018-12-26
Last updated
2019-08-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03786601. Inclusion in this directory is not an endorsement.